clorgyline has been researched along with Brain Vascular Disorders in 2 studies
Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakamura, S | 1 |
| Akiguchi, I | 1 |
| Kimura, J | 1 |
| Senjo, M | 1 |
| Yamazaki, N | 1 |
| Minami, M | 1 |
| Hirokami, M | 1 |
| Saito, H | 1 |
| Parvez, H | 1 |
2 other studies available for clorgyline and Brain Vascular Disorders
| Article | Year |
|---|---|
The histochemical demonstration of MPTP oxidation in the postmortem human striatum.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Aged, 80 and over; Caudate Nucleus; Cerebrovascu | 1993 |
Decreased monoamine oxidase activity in stroke-prone spontaneously hypertensive rat kidneys.
Topics: Animals; Cerebrovascular Disorders; Clorgyline; Hypertension; In Vitro Techniques; Kidney; Mitochond | 1986 |